Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Mustang Bio, Inc. MBIO
$4.66
+$0.09 (2.01%)
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
32885820.00000000
-
week52high
14.10
-
week52low
2.82
-
Revenue
0
-
P/E TTM
0
-
Beta
1.86193700
-
EPS
-10.80000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 20:05
Описание компании
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develops MB-107 and MB-207, a gene therapy program for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. The company also develops MB-102 CAR T therapies for blastic plasmacytoid dendritic cell neoplasm, acute myeloid leukemia, and myelodysplastic syndrome; MB-106 CAR T cell program for B cell non-hodgkin lymphoma and chronic lymphocytic leukemia; MB-104 CAR T for multiple myeloma and light chain amyloidosis; MB-101 CAR T cell program for glioblastoma; MB-103 CAR T for glioblastoma multiforme (GBM) and metastatic breast cancer to brain; MB-105 CAR T for prostate and pancreatic cancers; and MB-108, a next-generation oncolytic herpes simplex virus. It has license agreements with Nationwide Children's Hospital, CSL Behring; Mayo Clin Mayo Clinic; Leiden University Medical Centre; SIRION Biotech GmbH, and Minaris Regenerative Medicine GmbH. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| B. Riley Securities | Buy | Buy | 24 янв 2022 г. |
| BTIG | Buy | 18 мая 2021 г. | |
| B. Riley FBR | Buy | 02 окт 2020 г. | |
| Oppenheimer | Outperform | Outperform | 12 мая 2020 г. |
| HC Wainwright & Co. | Buy | 13 авг 2019 г. | |
| BTIG | Buy | Buy | 16 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Fortress Biotech, Inc. | A | 22630620 | 2807008 | 06 янв 2023 г. |
| Achenbach Brian | D | 144729 | 4374 | 14 дек 2021 г. |
| Achenbach Brian | A | 149103 | 22500 | 08 дек 2021 г. |
| Litchman Manuel MD | A | 1027987 | 65000 | 27 окт 2021 г. |
| Achenbach Brian | D | 126603 | 4450 | 12 окт 2021 г. |
| ROSENWALD LINDSAY A MD | A | 218423 | 1170 | 31 авг 2021 г. |
| Litchman Manuel MD | A | 962987 | 2746 | 31 авг 2021 г. |
| Litchman Manuel MD | A | 960241 | 86206 | 30 июл 2021 г. |
| Chill Adam J. | A | 107197 | 13774 | 28 июн 2021 г. |
| Herskowitz Neil | A | 115197 | 13774 | 28 июн 2021 г. |
Новостная лента
Mustang Bio: This Horse May Gallop Still
Seeking Alpha
23 сент 2022 г. в 16:55
We are circling back on small CAR-T developmental firm Mustang Bio, Inc. today for the first time in nearly a year and a half. The stock has been under pressure since we last looked in on this story, and the shares currently trade for less than net cash on the company's balance sheet.
Mustang Bio to Participate in Upcoming September 2022 Investor Conferences
GlobeNewsWire
08 сент 2022 г. в 08:00
WORCESTER, Mass., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that Manuel Litchman, M.D., President and Chief Executive Officer, will participate in two upcoming investor conferences in New York City.
What to Know About Buying Penny Stocks on June 23rd
PennyStocks
23 июн 2022 г. в 07:00
Here's what you need to know about trading penny stocks on June 23rd The post What to Know About Buying Penny Stocks on June 23rd appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Mustang Bio Posts Encouraging Interim Data From Gene Therapy Trial In Immunodeficiency
Benzinga
19 мая 2022 г. в 15:28
Mustang Bio Inc (NASDAQ: MBIO) announced interim data from the Phase 1/2 trial of MB-107, lentiviral gene therapy for X-linked severe combined immunodeficiency (X-SCID), also known as bubble boy disease, in newly diagnosed infants under the age of two. X-SCID is characterized by the.
Caribou Charges Ahead on Study Results
GuruFocus
17 мая 2022 г. в 15:07
Shares of Caribou Biosciences Inc. ( CRBU , Financial) are up more than 46% since last Thursday, leading the way for several beaten-down biotechs that also rose after investors got a look at the presentations the companies will be making at next month's European Hematology Association meeting.